Treatment of Hypertension Among African Americans: The Jackson Heart Study

Journal of Clinical Hypertension

Volumn 15, Issue 6, 2013, Pages 367-374

  Harman, Jane ^a   Walker, Evelyn R ^b   Charbonneau, Vicki ^a   Akylbekova, Ermeg L ^c   Nelson, Cheryl ^a   Wyatt, Sharon B ^d  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b MISSISSIPPI STATE DEPARTMENT OF HEALTH   (United States)

^c JACKSON STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE RECEPTOR; AMLODIPINE BESYLATE; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOOP DIURETIC AGENT; METOPROLOL TARTRATE; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT; TRIAMTERENE; VASODILATOR AGENT;

ADULT; AFRICAN AMERICAN; ALBUMINURIA; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; CLINICAL EXAMINATION; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

ADRENERGIC ALPHA-ANTAGONISTS; AFRICAN AMERICANS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DIURETICS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SEX FACTORS; TREATMENT OUTCOME;

EID: 84878788880     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12088     Document Type: Review

References (38)

1. Hansson L. The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. J Hypertens. 1996;14:537-544.
2. Hansson L. The Hypertension Optimal Treatment study and the importance of lowering blood pressure. J Hypertens Suppl. 1999;17:S9-S13.
3. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
4. Davis BR, Piller LB, Cutler JA, et al. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation. 2006;113:2201-2210.
5. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2000;356:1955-1964.
6. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289:2534-2544.
7. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
8. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165:2098-2104.
9. Ferdinand KC, Saunders E. Hypertension-related morbidity and mortality in African Americans-why we need to do better. J Clin Hypertens. 2006;8:21-30.
10. Wright JT Jr, Agodoa L, Contreras G, et al. Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med. 2002;162:1636-1643.
11. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010a;56:780-800.
12. Ferdinand KC. Recommendations for the management of special populations: racial and ethnic populations. Am J Hypertens. 2003;16:50S-54S.
13. Flack JM, Sica DA. Therapeutic considerations in the African-American patient with hypertension: considerations with calcium channel blocker therapy. J Clin Hypertens. 2005;7:9-14.
14. Fuqua SR, Wyatt SB, Andrew ME, et al. Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis. 2005;15(suppl 6):18-29.
15. Taylor HA Jr. The Jackson Heart Study: an overview. Ethn Dis. 2005;15(S6):1-3.
16. Wyatt SB, Akylbekova EL, Wofford MR, et al. Prevalence, awareness, treatment, and control of hypertension in the Jackson Heart Study. Hypertension. 2008;51:650-656.
17. Wolters Kluwer Health. Medi-Span. www.medispan.com Accessed March 8, 2012.
18. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
19. Keenan NL, Rosendorf KA. Prevalence of hypertension and controlled hypertension - United States, 2005-2008. MMWR Surveill Summ. 2011;60(suppl):94-97.
20. U.S.Census Bureau. Educational Attainment in the United States: 2010 - Detailed Tables. http://www.census.gov/hhes/socdemo/education/data/cps/2010/tables.html. Accessed March 12, 2013.
21. Egan BM, Zhao Y, Axon RN, et al. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011;124:1046-1058.
22. Egan BM, Laken MA. Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets? Curr Opin Cardiol. 2011;26:300-307.
23. Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J. 1991;121:664-669.
24. Hill MN, Bone LR, Kim MT, et al. Barriers to hypertension care and control in young urban black men. Am J Hypertens. 1999;12:951-958.
25. Collins R, Winkleby MA. African American women and men at high and low risk for hypertension: a signal detection analysis of NHANES III, 1988-1994. Prev Med. 2002;35:303-312.
26. Gerber LM, Mann SJ, McDonald MV, Chiu YL, Sridharan S, Feldman PH. Diuretic use in black patients with uncontrolled hypertension. Am J Hypertens. 2013;26:174-179.
27. ALLHAT Collaborators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
28. Stafford RS, Monti V, Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension. 2006;48:213-218.
29. Ferdinand KC, Armani AM. The management of hypertension in African Americans. Crit Pathw Cardiol. 2007;6:67-71.
30. Aksnes TA, Reims HM, Kjeldsen SE, Mancia G. Antihypertensive treatment and new-onset diabetes mellitus. Curr Hypertens Rep. 2005;7:298-303.
31. Manolis A, Doumas M. Antihypertensive treatment and sexual dysfunction. Curr Hypertens Rep. 2012;14:285-292.
32. Barksdale JD, Gardner SF. The impact of first-line antihypertensive drugs on erectile dysfunction. Pharmacotherapy. 1999;19:573-581.
33. McLaughlin T, Harnett J, Burhani S, Scott B. Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: a retrospective analysis of prescription claims. Am J Ther. 2005;12:605-611.
34. National High Blood Pressure Education Program Coordinating Committee. JNC7 Express: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; 2003. April 1, 2013.
35. Saunders E, Weir MR, Kong BW, et al. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med. 1990;150:1707-1713.
36. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328:914-921.
37. Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163:525-541.
38. Michel THB. Treatment of myocardial ischemia and hypertension. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman's the Pharmacological Basis of Therapeutics, 12th ed. New York, NY: McGraw-Hill; 2011.